Drug
Cardunolizumab
Cardunolizumab: highest development phase Phase 2, developed by Akeso. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Akeso
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cardunolizumab NCT06292689 | Phase 2 | Vulvar and Vaginal Cancer |
Latest
No recent events.
Follow Cardunolizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.